tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ambuja Cements Delivers Record Q3, Accelerates ‘One Cement Platform’ Strategy

Story Highlights
  • Ambuja Cements posted record Q3 FY26 results with PAT up 258 percent, record volumes and stronger margins.
  • The company advanced its One Cement Platform with ACC and Orient merger, new capacity and more renewables to boost scale and efficiency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ambuja Cements Delivers Record Q3, Accelerates ‘One Cement Platform’ Strategy

Claim 50% Off TipRanks Premium

Ambuja Cements Limited ( (IN:AMBUJACEM) ) has issued an update.

Ambuja Cements reported a strong performance for the quarter ended 31 December 2025, with profit after tax surging 258% year-on-year to Rs 3,781 crore, a 20% rise in revenue, and its highest-ever quarterly sales volume of 18.9 million tonnes, while EBITDA climbed 53% and margins improved on the back of higher trade and premium cement sales. The company remains debt-free with top-tier credit ratings, has operationalised a new 2.4 MTPA grinding unit at Marwar, advanced its ‘One Cement Platform’ strategy through the planned amalgamation of ACC and Orient Cement into Ambuja, and continued to scale both its digital CiNOC initiative and renewable energy portfolio, moves that collectively strengthen its market leadership, capital efficiency and long-term value proposition for stakeholders.

More about Ambuja Cements Limited

Ambuja Cements Limited, part of the diversified Adani portfolio, is one of the world’s largest building materials solutions companies, operating in the cement and construction materials industry. The company focuses on trade and premium cement sales, with a growing pan-India footprint and a total cement capacity now at 109 MTPA, supported by ongoing investments in capacity expansion and renewable energy.

Average Trading Volume: 115,368

Technical Sentiment Signal: Hold

Current Market Cap: 1319.7B INR

See more data about AMBUJACEM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1